Phlow is a pharmaceutical and public benefit corporation focused on providing more affordable, essential medicines through a advanced manufacturing process.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
04/05/2023 | Series B | $36MM | $xx.xx | $265.84MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,264,151
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
02/16/2021 | Series A | $20MM | $xx.xx | $133.33MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,333,333
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
5.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|